|
|
 |
|
ARNA: Arena Pharmaceuticals Inc - Stock News |
Enter Ticker:
|
|
| Nov 18, 2009 |
StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc. |
| Nov 17, 2009 |
Arena Pharmaceuticals Down 8% Since SmarTrend's Sell Recommendation |
| Nov 10, 2009 |
Arena Pharmaceuticals Down 13.2% Since SmarTrend's Sell Recommendation |
| Nov 09, 2009 |
Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments |
| Nov 04, 2009 |
Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009 |
| Nov 04, 2009 |
Vivus Inc Shares Fell 11.2% After Disappointing Earnings Report (VVUS,OREX,ARNA) |
| Nov 04, 2009 |
Unbiased Analysis on PHM, PPL, RT, RAD, ARNA and GNVC Posted onWallStSense.com |
| Nov 03, 2009 |
Zacks Analyst Blog Highlights: Clorox Company, Arena Pharmaceuticals, Vivus Inc., Orexigen Therapeutics and Amylin Pharmaceuticals |
| Nov 02, 2009 |
Arena Pharmaceuticals (ARNA) Bearish Technical Alert - Trend Down 15.2% |
| Oct 27, 2009 |
Vivus (VVUS) NewsBite - One Of Today's Top Losers |
| Oct 27, 2009 |
BUYINS.NET: BARE, BC, MPG, PNM, ARNA, GERN Expected To Be Lower After Earnings Releases on Thursday |
| Oct 27, 2009 |
New Data From Arena Pharmaceuticals' Pivotal BLOSSOM Trial of Lorcaserin Demonstrate Improvements in Patients' Body Composition, Cardiovascular Risk Factors and Quality of Life |
| Oct 26, 2009 |
MONSTERSTOX.COM: Monsterstox.com : Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) |
| Oct 26, 2009 |
ARNA: Additional Positive Data Presented re Lorcaserin for Obesity |
| Oct 26, 2009 |
AnalystChoice.com Provides Analytical Coverage on ARNA, CELG, TIVO,GNVC, TSTR and WTSLA |
| |
| ZACKS COMMENTARY FOR ARNA |
| Nov 03, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Clorox Company, Arena Pharmaceuticals, Vivus Inc., Orexigen Therapeutics and Amylin Pharmaceuticals | | Nov 02, 2009 | Zacks Blog: Amylin Strikes First on Obesity | | Sep 21, 2009 | Zacks Blog: Arena’s Lorcaserin Has Safety Edge | | Sep 21, 2009 | Zacks Equity Research: Report for ARNA | | Aug 04, 2009 | Zacks Blog: Obesity Update For Arena | | May 12, 2009 | Zacks Blog: The Skinny on ARNA's Lorcaserin | | Mar 30, 2009 | Zacks Blog: Arena Pharma Results Disappoint | | Mar 13, 2009 | Zacks Blog: Arena Study Results Crucial | | Feb 27, 2009 | Zacks Blog: Options Trading in Biotech | | Jan 29, 2009 | Zacks Blog: Zacks #1 Rank Additions for Thursday | | Jan 06, 2009 | Zacks Analyst Interviews: Pharmaceuticals | | Jan 02, 2009 | Zacks Blog: Zacks #1 Rank Additions for Friday |
|
|
Sponsored Links 
-0.03